Sean Nugent is a Research Formulation Scientist II at Viridian Therapeutics, Inc., with extensive experience in formulation science gained from previous roles at the National Institute of Allergy and Infectious Diseases, MedImmune, Imquest BioSciences, and Cambridge Polymer Group. Sean has held various positions including Scientist and Associate Scientist II at NIAID, and Research Associate roles at MedImmune and other organizations. Sean obtained a Master of Science in Chemistry from American University in 2018 and a Bachelor of Science in Chemistry from Emmanuel College in 2010.